Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP1276272.RAF9nbXUHv4u8NbH1pL5zbAssXXB71Og041Bv3oUIoVA0130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP1276272.RAF9nbXUHv4u8NbH1pL5zbAssXXB71Og041Bv3oUIoVA0130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP1276272.RAF9nbXUHv4u8NbH1pL5zbAssXXB71Og041Bv3oUIoVA0130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP1276272.RAF9nbXUHv4u8NbH1pL5zbAssXXB71Og041Bv3oUIoVA0130_provenance.
- NP1276272.RAF9nbXUHv4u8NbH1pL5zbAssXXB71Og041Bv3oUIoVA0130_assertion description "[This single-arm phase II study enrolled patients with stage I to IIIA (T ? 1 cm) estrogen receptor-negative (? 5%), progesterone receptor-negative (? 5%), and human epidermal growth factor receptor 2-negative or BRCA1/2 mutation-associated breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1276272.RAF9nbXUHv4u8NbH1pL5zbAssXXB71Og041Bv3oUIoVA0130_provenance.
- NP1276272.RAF9nbXUHv4u8NbH1pL5zbAssXXB71Og041Bv3oUIoVA0130_assertion evidence source_evidence_literature NP1276272.RAF9nbXUHv4u8NbH1pL5zbAssXXB71Og041Bv3oUIoVA0130_provenance.
- NP1276272.RAF9nbXUHv4u8NbH1pL5zbAssXXB71Og041Bv3oUIoVA0130_assertion SIO_000772 25847929 NP1276272.RAF9nbXUHv4u8NbH1pL5zbAssXXB71Og041Bv3oUIoVA0130_provenance.
- NP1276272.RAF9nbXUHv4u8NbH1pL5zbAssXXB71Og041Bv3oUIoVA0130_assertion wasDerivedFrom befree-2016 NP1276272.RAF9nbXUHv4u8NbH1pL5zbAssXXB71Og041Bv3oUIoVA0130_provenance.
- NP1276272.RAF9nbXUHv4u8NbH1pL5zbAssXXB71Og041Bv3oUIoVA0130_assertion wasGeneratedBy ECO_0000203 NP1276272.RAF9nbXUHv4u8NbH1pL5zbAssXXB71Og041Bv3oUIoVA0130_provenance.
- befree-2016 importedOn "2016-02-19" NP1276272.RAF9nbXUHv4u8NbH1pL5zbAssXXB71Og041Bv3oUIoVA0130_provenance.